Safety evaluation of a food enzyme containing trypsin and chymotrypsin from porcine pancreas.
EC 3.4.21.1
EC 3.4.21.4
Trypsin
chymotrypsin
pig pancreas
Journal
EFSA journal. European Food Safety Authority
ISSN: 1831-4732
Titre abrégé: EFSA J
Pays: United States
ID NLM: 101642076
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
entrez:
18
6
2021
pubmed:
19
6
2021
medline:
19
6
2021
Statut:
epublish
Résumé
The food enzyme is a serine protease complex containing trypsin (EC 3.4.21.4) and chymotrypsin (EC 3.4.21.1) obtained from porcine pancreas by Paninkret Chem.-Pharm. Werk GmbH. The food enzyme is currently only used in protein processing to hydrolyse milk proteins. Milk protein hydrolysates and peptides are mainly used in formulae intended to have reduced allergenicity. Based on the recommended use level and the high consumption of formulae in very young babies, dietary exposure to the food enzyme-total organic solids (TOS) was estimated to be 180 mg TOS/kg body weight (bw) per day for infants and toddlers. Toxicological evaluation was based on the available clinical studies with pancreatic enzymes. Hypersensitivity to the product was identified as the major side effect. However, the intact enzymes are inactivated during preparation of food products; therefore, the Panel considered that the likelihood of adverse effects of the intact enzyme to occur is low. The Panel considered that a risk of allergic sensitisation to these protein hydrolysates after consumption cannot be excluded, but the likelihood of occurrence was considered to be low. Based on the origin of the food enzyme from edible parts of animals, the data provided and the evaluation of clinical studies with pancreatic enzymes and the estimated dietary exposure, the Panel concluded that the food enzyme does not give rise to safety concerns when used in the production of infant formulae based on milk protein hydrolysates.
Identifiants
pubmed: 34140999
doi: 10.2903/j.efsa.2021.6640
pii: EFS26640
pmc: PMC8207344
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e06640Informations de copyright
© 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
Références
N Engl J Med. 1975 May 15;292(20):1050-3
pubmed: 47609
Dtsch Arztebl Int. 2014 May 23;111(21):367-75
pubmed: 24939374
J Cyst Fibros. 2015 Mar;14(2):275-81
pubmed: 25066363
Clin Ther. 2010 Jan;32(1):89-103
pubmed: 20171415
Allergy. 2005 Nov;60(11):1440-5
pubmed: 16197479
EFSA J. 2021 Jan 06;19(1):e06369
pubmed: 33437322
Acta Paediatr. 2000 Jan;89(1):18-21
pubmed: 10677051
Ann Allergy Asthma Immunol. 2018 Sep;121(3):360-365
pubmed: 29860051
EFSA J. 2020 Nov 10;18(11):e06266
pubmed: 33204307
Am J Gastroenterol. 2010 Oct;105(10):2276-86
pubmed: 20502447
Cochrane Database Syst Rev. 2020 Aug 5;8:CD008227
pubmed: 32761612
J Allergy Clin Immunol. 1999 Sep;104(3 Pt 1):700-1
pubmed: 10482849
Pancreas. 2013 Aug;42(6):983-9
pubmed: 23587850
Clin Pediatr (Phila). 2014 Jun;53(6):585-92
pubmed: 24662422
Expert Opin Drug Saf. 2011 Mar;10(2):197-203
pubmed: 21342076
J Pediatr. 1991 Apr;118(4 Pt 1):520-5
pubmed: 2007924
JOP. 2012 Sep 10;13(5):476-81
pubmed: 22964953
Allergy. 2008 Aug;63(8):1071-6
pubmed: 18691309
Aliment Pharmacol Ther. 2011 May;33(10):1152-61
pubmed: 21418260
Pediatr Pulmonol. 1991;10(2):79-85
pubmed: 2030925
EFSA J. 2017 May 31;15(5):e04849
pubmed: 32625502
Arch Dis Child. 1996 May;74(5):464-8
pubmed: 8669970